Milestone Pharmaceuticals Inc (MIST) (Q3 2026) Earnings Call Highlights: Cardamist Scripts Jump ...
Milestone Pharmaceuticals Inc (MIST) posted strong sequential growth for Cardamist and expanded formulary coverage, while a 30% expense reduction aims to fund operations through the Phase 3 Related Stocks: MIST ,